指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

多学会欧洲共识:同时性结直肠癌与肝转移的术语、诊断和管理

Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE.
指南 / 共识 · Br J Surg · 2023-01-01
一句话结论该多学科共识明确了同时性肝转移、早期/晚期异时性肝转移及消失性转移的术语定义,并就肿瘤委员会构成、急诊与择期评估及治疗路径提出12条关键声明。

该共识由E-AHPBA联合ESSO、ESCP、ESGAR、CIRSE等多组织制定,聚焦同时性结直肠癌与肝转移的术语、诊断和管理。通过在线Delphi流程(≥70%同意)形成12条关键声明。共识定义了同时性肝转移、早期/晚期异时性肝转移及消失性转移,并对肿瘤委员会构成、急诊与择期临床评估、系统化疗、同期手术及分期手术路径提供指导。其推荐为临床医生管理此类复杂患者提供实用框架。

要点

  • 同时性肝转移定义为原发肿瘤就诊时即发现的肝转移。
  • 早期异时性肝转移:就诊时无、原发肿瘤诊断后12个月内检出;晚期异时性:12个月后检出。
  • 消失性转移指系统化疗后MRI上不再 detectable 的病灶。
  • 共识就肿瘤委员会推荐构成、急诊与择期场景的临床评估提供指导。
  • 治疗路径包括系统化疗、同期手术及以结直肠或肝脏为导向的分期手术。

适用人群与场景

  • 同时性结直肠癌与肝转移患者。
  • 急诊与择期场景下的临床评估。

诊断标准与关键阈值

  • 同时性肝转移:原发肿瘤就诊时检出的肝转移。
  • 早期异时性肝转移:就诊时不存在、原发肿瘤诊断后12个月内检出的转移。
  • 晚期异时性肝转移:原发肿瘤诊断12个月后检出的转移。
  • 消失性转移:系统化疗后MRI上不再 detectable 的病灶。

处置流程与药物剂量

  • 治疗路径包括系统化疗、同期手术,以及以结直肠或肝脏为导向手术作为第一步的分期策略。
  • 讨论了肺转移的管理及微创手术的作用。

研究设计与关键结果

  • 该共识为多组织、多学科共识,通过在线Delphi流程形成声明,≥70%同意者进入最终会议审议,最终文件包含12条关键声明。
  • 共识就肿瘤委员会推荐构成、急诊与择期临床评估提供指导。
  • 共识聚焦治疗路径,包括系统化疗、同期手术及以结直肠或肝脏为导向手术为首步的分期策略,并讨论了肺转移管理和微创手术的作用。

证据类型、等级与局限

  • 证据类型:多组织、多学科共识(指南)。
  • 共识形成方法:在线Delphi流程,≥70%同意率的声明在最终会议上审议。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 该共识的术语定义为急诊/ICU及肿瘤委员会沟通提供统一标准:同时性肝转移指原发肿瘤就诊时检出,早期异时性指诊断后12个月内检出,晚期异时性指12个月后检出。
  • 共识推荐就肿瘤委员会构成及急诊与择期临床评估提供指导,临床可据此规范多学科讨论流程。
  • 治疗路径需覆盖系统化疗、同期手术及以结直肠或肝脏为导向的分期手术,并考虑肺转移管理和微创手术的作用。

指南或共识出处

  • Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE(Br J Surg)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Contemporary management of patients with synchronous colorectal cancer and liver metastases is complex. The aim of this project was to provide a practical framework for care of patients with synchronous colorectal cancer and liver metastases, with a focus on terminology, diagnosis, and management.

METHODS: This project was a multiorganizational, multidisciplinary consensus. The consensus group produced statements which focused on terminology, diagnosis, and management. Statements were refined during an online Delphi process, and those with 70 per cent agreement or above were reviewed at a final meeting. Iterations of the report were shared by electronic mail to arrive at a final agreed document comprising 12 key statements.

RESULTS: Synchronous liver metastases are those detected at the time of presentation of the primary tumour. The term 'early metachronous metastases' applies to those absent at presentation but detected within 12 months of diagnosis of the primary tumour, the term 'late metachronous metastases' applies to those detected after 12 months. 'Disappearing metastases' applies to lesions that are no longer detectable on MRI after systemic chemotherapy. Guidance was provided on the recommended composition of tumour boards, and clinical assessment in emergency and elective settings. The consensus focused on treatment pathways, including systemic chemotherapy, synchronous surgery, and the staged approach with either colorectal or liver-directed surgery as first step. Management of pulmonary metastases and the role of minimally invasive surgery was discussed.

CONCLUSION: The recommendations of this contemporary consensus provide information of practical value to clinicians managing patients with synchronous colorectal cancer and liver metastases.

来源:Br J Surg,查看原文。版权归原作者所有。

参考来源

  1. Siriwardena AK, Serrablo A, Fretland ÅA, et al. Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE. Br J Surg. 2023. PMID: 37442562. doi:10.1093/bjs/znad124

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。